UK markets closed
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,207.13 +444.10 (+2.50%) CRUDE OIL
79.01 +0.01 (+0.01%) GOLD FUTURES
2,311.40 +0.40 (+0.02%) DOW
38,067.94 +164.65 (+0.43%) Bitcoin GBP
47,156.82 +1,663.33 (+3.66%)
BioMarin Pharmaceutical Inc. (BMRN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 12:49PM EDT. Market open.
| Previous close | 83.33 |
| Open | 82.91 |
| Bid | 84.47 x 400 |
| Ask | 84.71 x 100 |
| Day's range | 81.43 - 84.69 |
| 52-week range | 76.02 - 99.56 |
| Volume | |
| Avg. volume | 1,577,208 |
| Market cap | 16.057B |
| Beta (5Y monthly) | 0.32 |
| PE ratio (TTM) | 79.78 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
BioMarin Pharmaceutical Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Last week, you might have seen that BioMarin Pharmaceutical Inc. ( NASDAQ:BMRN ) released its first-quarter result to...
- GuruFocus.com
Beyond the Balance Sheet: What SWOT Reveals About Biomarin Pharmaceutical Inc (BMRN)
Insightful Analysis of Biomarin Pharmaceutical Inc's Strengths, Weaknesses, Opportunities, and Threats
- Insider Monkey
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q1 2024 Earnings Call Transcript
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q1 2024 Earnings Call Transcript April 24, 2024 BioMarin Pharmaceutical Inc. beats earnings expectations. Reported EPS is $0.71, expectations were $0.6. BioMarin Pharmaceutical Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon. My name […]
© 2024 Yahoo. All rights reserved.